| 11 |
Dong-A ST partners with KIST for breakthrough in inflammatory bowel disease treatment
|
2024-02-19 |
638 |
| 10 |
Dong-A ST NeuroBo Pharmaceuticals Initiates Phase 2 Part 2 Clinical Trial for DA-1241
|
2024-02-19 |
507 |
| 9 |
Dong-A ST Signs R&D Agreement with Eleven Therapeutics for RNA-based Gene Therapy
|
2024-01-15 |
792 |
| 8 |
Dong-A ST acquires AbTis to develop new ADCs
|
2024-01-15 |
1028 |
| 7 |
Dong-A ST advances phase 1/2a study of cancer immunotherapy
|
2023-12-19 |
523 |
| 6 |
Dong-A ST to develop AAV gene therapy in collaboration with UMass Chan
|
2023-12-19 |
548 |
| 5 |
Dong-A ST Gears Up for Global Growth at CPHI Worldwide 2023 in Barcelona
|
2023-12-19 |
655 |
| 4 |
Dong-A ST Unveils Cutting-Edge Immuno-Oncology Drug Candidate 'DA-4511' at AACR-NCI-EORTC 2023
|
2023-12-19 |
563 |
| 3 |
HK inno.N set to develop 5th-generation lung cancer drug
|
2023-12-19 |
753 |
| 2 |
Dong-A ST eyes Europe market with Stelara biosimilar
|
2023-12-18 |
582 |
